|
Volumn 16, Issue 3, 2001, Pages 232-239
|
Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
BIOCHEMICAL MARKER;
CD11B ANTIGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 6;
INTERLEUKIN 8;
LACTOFERRIN;
PADGEM PROTEIN;
ADULT;
AGED;
ARTICLE;
CARDIOPULMONARY BYPASS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HEART VALVE SURGERY;
HUMAN;
INFLAMMATION;
MALE;
POSTOPERATIVE PERIOD;
PREOPERATIVE EVALUATION;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY BURST;
SURGICAL PATIENT;
AGED;
CARDIOPULMONARY BYPASS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
NEUTROPHILS;
NF-KAPPA B;
PREOPERATIVE CARE;
PROSPECTIVE STUDIES;
PYRROLES;
|
EID: 0035695822
PISSN: 08860440
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1540-8191.2001.tb00513.x Document Type: Article |
Times cited : (35)
|
References (28)
|